Trial Profile
Randomized trial of telmisartan and/or enalapril on renoprotective effects for patients of chronic renal diseases with hypertension.
Status:
Discontinued
Phase of Trial:
Phase III
Latest Information Update: 20 Jul 2015
Price :
$35
*
At a glance
- Drugs Enalapril (Primary) ; Telmisartan (Primary)
- Indications Hypertension
- Focus Therapeutic Use
- 14 Jul 2015 Status changed from recruiting to discontinued as per University Hospital Medical Information Network - Japan.
- 20 Jan 2012 New trial record